Lactobacillus reuteri

Introduction to Lactobacillus reuteri

Lactobacillus reuteri—recently reclassified by taxonomists as Limosilactobacillus reuteri—is one of the most fascinating and extensively researched probiotic species in the world. Unlike many transient bacteria found in fermented foods, L. reuteri is an indigenous species to the human gastrointestinal tract. It has co-evolved with humans over millions of years, passed down from mother to child during birth and breastfeeding.

However, modern lifestyles have taken a toll on our native microbiome. Diets low in fermentable fibers, increased sanitation, and the widespread use of antibiotics have led to a vast depletion of L. reuteri in the modern human gut. Today, many individuals lack this crucial keystone species, making targeted supplementation an area of intense clinical interest.

The Reclassification: Limosilactobacillus reuteri

If you are reading modern scientific literature or looking at newly updated supplement labels, you might notice a name change. In April 2020, the massive and highly diverse Lactobacillus genus was officially split into 25 different genera to better reflect the genetic and evolutionary realities of these bacteria. As a result, Lactobacillus reuteri was renamed Limosilactobacillus reuteri. Despite the new prefix, it is the exact same bacterium with the exact same health benefits. Many commercial products still use the legacy name Lactobacillus reuteri for consumer recognition.

Primary Mechanisms of Action

How does a microscopic organism exert such profound effects on human health? The efficacy of L. reuteri comes down to three primary biochemical mechanisms:

1. Reuterin Synthesis and Antimicrobial Activity The most famous characteristic of L. reuteri is its ability to produce a unique antimicrobial compound called reuterin (3-hydroxypropionaldehyde). When L. reuteri ferments glycerol in the gut, it secretes reuterin, which acts as a broad-spectrum antibiotic. Reuterin induces severe oxidative stress in pathogenic bacteria, fungi, and protozoa, effectively neutralizing them. Remarkably, L. reuteri produces reuterin in quantities sufficient to inhibit pathogens like E. coli and Salmonella without harming the beneficial, commensal bacteria that make up a healthy microbiome.

2. Immunomodulation and T-Cell Regulation L. reuteri does not just fight bad bacteria; it actively communicates with your immune system. By interacting with dendritic cells in the gut lining, L. reuteri promotes the generation of regulatory T cells (Tregs). These cells act as the immune system's "brakes," increasing the production of anti-inflammatory cytokines like IL-10 while suppressing pro-inflammatory markers like TNF-alpha. This immunomodulatory effect is a key reason why L. reuteri is so effective at soothing inflammatory gut conditions and reducing visceral pain.

3. Intestinal Barrier Fortification A healthy gut lining is selectively permeable—it absorbs nutrients while keeping toxins and undigested food particles out of the bloodstream. L. reuteri upregulates the expression of tight junction proteins (such as ZO-1 and occludin) that seal the gaps between intestinal cells. By tightening this barrier, it helps prevent "leaky gut" and the subsequent systemic inflammation caused by metabolic endotoxemia.

Clinical Efficacy and Health Benefits

With over 250 clinical studies and 10 meta-analyses covering more than 25,000 participants, the evidence base for L. reuteri is exceptionally robust.

Gastrointestinal Health and Diarrhea Examine.com awards L. reuteri a Grade A (High Confidence) rating for its ability to reduce symptoms of infectious diarrhea. By competitively excluding pathogens and secreting reuterin, it helps the gut clear infections faster, slightly reducing the duration of diarrhea, particularly in children.

Infantile Colic Perhaps the most celebrated use of L. reuteri is in pediatric medicine. Excessive crying in infants, known as colic, is a major source of distress for families. Clinical trials show that administering L. reuteri drops (specifically the DSM 17938 strain) to infants significantly reduces daily crying time. It is believed to work by reducing gut inflammation, improving motility, and decreasing visceral pain perception.

Helicobacter pylori Eradication Helicobacter pylori is a pathogenic bacterium that colonizes the stomach, leading to ulcers and increasing the risk of gastric cancer. Standard treatment involves aggressive courses of antibiotics and proton pump inhibitors (PPIs), which often cause severe gastrointestinal side effects. Taking L. reuteri alongside standard H. pylori therapy has been shown to significantly reduce these side effects, improving patient compliance. While it may not eradicate H. pylori on its own, it is a highly effective adjunct therapy.

Constipation and Stomach Pain Evidence suggests that L. reuteri can help regulate bowel movements, reducing symptoms of constipation. It also appears effective in reducing general, undiagnosed stomach pain in children.

What It Does NOT Do It is equally important to understand the limitations of probiotics. Based on Grade D evidence from multiple studies, L. reuteri does not appear to have any significant effect on blood glucose levels, Apolipoprotein A (a cholesterol marker), B cell counts, or bilirubin levels. While it may offer a very minor reduction in total cholesterol, it should not be relied upon as a primary metabolic or cardiovascular treatment.

Strain Specificity: Not All L. reuteri Are Equal

In the world of probiotics, the strain matters just as much as the species. The genetic makeup of different L. reuteri strains dictates their specific health benefits.

DSM 17938 (Protectis): This is the most commercially available and heavily researched strain, owned by BioGaia. It is the daughter strain of the original ATCC 55730 (which is no longer commercially available). It is the go-to strain for infant colic, diarrhea, and general GI health. ATCC PTA 5289 & DSM 17938 (Prodentis): Often combined in lozenge form, these strains are specifically tailored for oral health, helping to manage gingivitis and canker sores. NCIMB 30242: This strain has been studied specifically for its potential to support cardiovascular health and manage cholesterol levels.

Dosing Protocols and Best Practices

Clinical studies utilize a wide range of dosages, typically falling between 10 million ($1 \times 10^7$) and 100 billion ($1 \times 10^{11}$) Colony-Forming Units (CFUs) per day.

For adults seeking general gut health or H. pylori support, a daily dose of 1 billion to 10 billion CFUs is standard. For infants and children, dosages are strictly limited, usually capped at 1 billion ($1 \times 10^9$) CFUs daily.

Because L. reuteri does not permanently colonize the gut in most modern humans, it must be consumed frequently. Once supplementation stops, the bacteria are typically washed out of the gastrointestinal tract within a few weeks.

Safety, Tolerability, and Contraindications

L. reuteri is generally recognized as safe (GRAS) and is well-tolerated by most populations. It has been used safely in clinical trials for up to 6 months in adults, 12 weeks in older children, and 4 weeks in infants.

Side Effects: Mild gastrointestinal changes, such as temporary bloating, gas, or changes in bowel habits (mild diarrhea or constipation), may occur during the first few days of supplementation as the gut microbiome adjusts.

Contraindications: Immunocompromised Individuals: People with severely weakened immune systems (e.g., those undergoing chemotherapy, organ transplant recipients, or those with advanced HIV/AIDS) should avoid live probiotics, as there is a rare but documented risk of the bacteria entering the bloodstream and causing bacteremia. Premature Infants: While safe for full-term infants, there is insufficient safety data regarding the use of L. reuteri in very small, premature infants.

Drug Interactions: Drugs.com lists 362 moderate drug interactions for L. reuteri. The most notable interactions are with antibiotics (which will kill the probiotic bacteria if taken simultaneously) and immunosuppressants. If you are taking antibiotics, it is generally recommended to space your probiotic dose at least 2-4 hours apart from your antibiotic dose.